Xianquan Zhan

Comparative proteomics analysis of human lung squamous carcinoma.

Proteomic comparison of two-dimensional gel electrophoresis profiles from human lung squamous carcinoma and normal bronchial epithelial tissues.

Identification of differentially expressed proteins in the spinal cord of neuropathic pain models with PKCgamma silence by proteomic analysis.

Proteomic and bioinformatics analyses of mouse liver microsomes.

Mitochondrial proteomics of nasopharyngeal carcinoma metastasis.

Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.

[Effect of DJ-1 siRNA on biological behavior of human lung squamous carcinoma SK-MES-1 cells].

Pituitary adenoma nitroproteomics: current status and perspectives.

Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.

Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line.

Mass spectrometry analysis of nitrotyrosine-containing proteins.

VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.

VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.

Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas.

Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.

Proteomic and functional profiles of a follicle-stimulating hormone positive human nonfunctional pituitary adenoma.

EPMA position paper in cancer: current overview and future perspectives.

Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry.

Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry.

Exploration of Molecular Network Variations in Different Subtypes of Human Non-functional Pituitary Adenomas.

Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.

Editorial: Systems Biological Aspects of Pituitary Tumors.

Pattern recognition for predictive, preventive, and personalized medicine in cancer.

Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.

Proteomic Identification of an Upregulated Isoform of Annexin A3 in the Spinal Cords of Rats in a Neuropathic Pain Model.

How many proteins can be identified in a 2DE gel spot within an analysis of a complex human cancer tissue proteome?

Protein tyrosine nitration in lung cancer: current research status and future perspectives.

The crucial role of multiomic approach in cancer research and clinically relevant outcomes.

The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.

Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas.

The differentially mitochondrial proteomic dataset in human ovarian cancer relative to control tissues.

Prolactin Variants in Human Pituitaries and Pituitary Adenomas Identified With Two-Dimensional Gel Electrophoresis and Mass Spectrometry.

Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues.

The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas.

Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics.

Quantitative analysis of the human ovarian carcinoma mitochondrial phosphoproteome.

Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.

Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas.

Innovating the Concept and Practice of Two-Dimensional Gel Electrophoresis in the Analysis of Proteomes at the Proteoform Level.